{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Red blood cells count decreased",
                    "n": "5",
                    "percentage": "83",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Leukopenia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Neutropenia",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "AST increase",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "ALT increase",
                    "n": "4",
                    "percentage": "67",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "GGT increase",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Hyponatremia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Nausea",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Vomiting",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['33']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Abdominal pain",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Oral mucositis",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dyspepsia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Dysgeusia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Anorexia",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "3",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Arthralgia",
                    "n": "2",
                    "percentage": "33",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Myalgia",
                    "n": "1",
                    "percentage": "17",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "LVEF decrease",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 1",
                    "AE": "Pericardial effusion",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Red blood cells count decreased",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Red blood cells count decreased",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Red blood cells count decreased",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Red blood cells count decreased",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Red blood cells count decreased",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Red blood cells count decreased",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Leukopenia",
                    "n": "2",
                    "percentage": "50",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Neutropenia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "AST increase",
                    "n": "4",
                    "percentage": "100",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "ALT increase",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "GGT increase",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hypocalcemia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Hyponatremia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Nausea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Vomiting",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Diarrhea",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Abdominal pain",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Oral mucositis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dyspepsia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Dysgeusia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Anorexia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Alopecia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Fatigue",
                    "n": "3",
                    "percentage": "75",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pneumonitis",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Peripheral sensory neuropathy",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Arthralgia",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Myalgia",
                    "n": "-",
                    "percentage": "-",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "LVEF decrease",
                    "n": "1",
                    "percentage": "25",
                    "comparison to": "-"
                },
                "measures": "[statistical representation, -]",
                "outcomes": "[outcome, -]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "dose level": "Level 2",
                    "AE": "Pericardial effusion",
                    "n": "-"
                }
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 48,
    "total_ground_truth_claims": 126,
    "number_of_matches": 20
}